Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 192,399 | 177,376 | 196,873 | 179,516 | 181,099 |
| Cost of Goods | 44,164 | 36,413 | 40,299 | 34,278 | 40,866 |
| Gross Profit | 148,235 | 140,963 | 156,574 | 145,238 | 140,233 |
| Operating Expenses | 144,132 | 134,474 | 154,533 | 139,154 | 132,600 |
| Operating Income | 4,267 | 6,902 | 2,340 | 6,362 | 8,499 |
| Interest Expense | 3,622 | 3,699 | 3,892 | 4,279 | 4,695 |
| Other Income | 1,910 | 1,795 | 2,123 | 7,441 | -5,731 |
| Pre-tax Income | 2,555 | 4,998 | 571 | 9,524 | -1,927 |
| Income Tax | -2,098 | 2,082 | -1,066 | 4,092 | 2,920 |
| Net Income Continuous | 4,653 | 2,916 | 1,637 | 5,432 | -4,847 |
| Net Income | $4,653 | $2,916 | $1,637 | $5,432 | $-4,847 |
| EPS Basic Total Ops | 0.12 | 0.07 | 0.05 | 0.12 | -0.11 |
| EPS Basic Continuous Ops | 0.12 | 0.07 | 0.04 | 0.12 | -0.11 |
| EPS Diluted Total Ops | 0.12 | 0.07 | 0.05 | 0.12 | -0.11 |
| EPS Diluted Continuous Ops | 0.12 | 0.07 | 0.04 | 0.12 | -0.11 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.34 | 0.32 | 0.46 | 0.47 |
| EBITDA(a) | $27,372 | $28,240 | $19,331 | $28,049 | $38,789 |